The first challenge to Johnson & Johnson ’s coronary angioplasty business came from Guidant Corp. ’s introduction of a stent with greater flexibility and an improved delivery balloon catheter. T
by Stephen Levin and Tom Salemi More than a decade ago venture capitalists identified neurostimulation as a fertile new field for investment. The use of energy pulses—usually electricity—to manipulate
Heart Technology is one of the great success stories in medical devices over the past 20 years. But you’d never have predicted that given the company’s early experiences. by David Cassak There are so
In the coronary arteries, stents have relegated atherectomy devices to niche applications. But in peripheral vascular disease, plaque-clearing devices have found their true market. By Mary Stuart For